Missouri Woman Sues Vioxx Maker for Daughter's Death

A Missouri woman has sued the maker of arthritis drug Vioxx over the 2002 death of her daughter. The suit, filed Friday, came a day after Merck & Co. pulled the medication from shelves over fears that users faced increased risk of heart attack and stroke. Caroline Nevels claims Merck knew of Vioxx's risks long before its Thursday announcement. The plaintiffs attorney said the suit was the first of its kind in the state, though similar suits are in the works across the country.

X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
A Missouri woman has sued the maker of arthritis drug Vioxx over the 2002 death of her daughter. The suit filed Friday by Caroline Nevels of Lexington, Mo., came a day after Merck & Co. pulled the medication from shelves over fears users faced increased risk of heart attack and stroke. Nevels says her 34-year-old daughter, Shelly South, took Vioxx for 2 1/2 years before dying of a heart attack in November 2002. She claims Merck knew of the risks of Vioxx long before its announcement Thursday. A spokeswoman for Merck said she had not seen the lawsuit and the company would not comment on litigation. Also named in the suit is Dr. Waclaw Alex Dymek, the Carrollton, Mo., physician who prescribed the drug to South. Nevels claims Dymek failed to diagnose the severity of her daughter’s heart condition and prescribed Vioxx despite her medical history. The doctor said he had not seen the lawsuit and did not remember treating South. Kenneth McClain, the plaintiffs attorney, said the suit was the first of its kind in Missouri, though similar lawsuits are in the works across the country. One attorney claims to represent 58 patients around the U.S. who say they have been harmed by Vioxx, including people who suffered a heart attack, stroke, internal bleeding or kidney failure. The lawsuit, filed as a class action although Nevels is the only named plaintiff, seeks unspecified compensatory and punitive damages and money for medical monitoring of Vioxx users. Merck is one of the world’s largest drug makers, and Vioxx is its popular medication for arthritis as well as acute pain and disorders such as carpal tunnel syndrome. The drug accounted for $2.5 billion in worldwide sales last year. Some 84 million prescriptions have been filled since the drug’s introduction. Copyright 2004 Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.

Want to continue reading?
Become a Free ALM Digital Reader.

Benefits of a Digital Membership:

  • Free access to 3 articles* every 30 days
  • Access to the entire ALM network of websites
  • Unlimited access to the ALM suite of newsletters
  • Build custom alerts on any search topic of your choosing
  • Search by a wide range of topics

*May exclude premium content
Already have an account?

Trending Stories

 

Featured Product

Global Briefing

A weekly, curated selection of our international content from around the globe, across the business of law, in-house, regulatory, technology and more, with expert insights from our senior editors.

Learn More

More from ALM

 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Privacy Policy

About Us / Contact Us / Site Map / Advertise With Us/ Customer Service / Terms of Service/ FAQ / Privacy Policy

Publications

Law Topics

Rankings

More

Law.com

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.